Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor α and Interlukin‐6 in astrocytes

Authors:

Abstract
Dehydroepiandrosterone (DHEA) is a native neurosteroid with immunomodulating activity. DHEA effectively protects animals from several viral, bacterial and parasitic infections and it was suggested that its age‐associated decline is related with immunosenescence. In the present study we examined the ability of DHEA to inhibit the production of inflammatory mediators by mycoplasma‐stimulated glial cells and to change the course of acute central nervous system (CNS) inflammatory disease in vivo. Addition of DHEA (10 μg/ml) markedly inhibited tumor necrosis factor α (TNFα) and interlukin‐6 (IL‐6) production (98 and 95%, respectively), whereas nitric oxide (NO) and prostaglandin E2 (PGE2) production was not affected. However, daily administration of 0.5 mg DHEA to mice or 5 mg to rats did not change the clinical outcome of experimental autoimmune encephalomyelitis (EAE).
Funding Information
  • Israel Ministry of Health
  • Hilda Katz Blaustein Endowment Fund
  • Lena P. Harvey Neurological Fund

This publication has 36 references indexed in Scilit: